P. Madeddu et al., Role of the bradykinin B-2 receptor in the maturation of blood pressure phenotype, lesson from transgenic and knockout mice, IMMUNOPHARM, 44(1-2), 1999, pp. 9-13
The binding of bradykinin (BK) to its B-2 receptor results in a wide spectr
um of biological effects including vasodilation, smooth muscle contraction
and relaxation, pain, and inflammation. In order to gain a better insight i
nto the physiological function of this potent vasoactive peptide, murine mo
dels have been created by the use of gene insertion or deletion. The result
s of studies using these strategies are revisited in the present article. I
n transgenic mice harboring the human BK B-2 receptor cDNA (cHBKR), express
ion of the transgene was identified in the aorta, brain, heart, lung, liver
, kidney, uterus and prostate gland by RT-PCR Southern blot analysis. These
mice displayed an exaggerated hypotensive response to intra-aortic injecti
on of BK, whereas the blood pressure of knockout mice, homozygous for targe
ted disruption of the endogenous gene, was insensitive to BK. Two transgeni
c mouse lines expressing the human BK B-2 receptor showed a significant red
uction of systolic tail-cuff blood pressure (84 +/- 1 mm Hg, n = 28; 80 +/-
1 mm Hg, n = 24; P < 0.001) compared with the control littermates (97 +/-
1 mm Hg, n = 52). Systolic blood pressure was elevated in BK B-2 receptor k
nockout mice (124 +/- 1 mm Hg, n = 38). In heterozygous mice, systolic bloo
d pressure was similar to that of controls until 5 month-old, then it raise
d to the elevated levels of knockout mice at 7 months of age. Together thes
e data indicate that kinins acting through the B-2 receptor play a role in
the development of the blood pressure phenotype. (C) 1999 Elsevier Science
B.V. All rights reserved.